CerviGuard: screening workflow product
CerviGuard gives cervical-screening teams one traceable path from a new case to a signed-off follow-up decision.
SmartClover develops CerviGuard and DataGems and advances current and future products through applied research, permissioned cloud-on-edge infrastructure, and cybersecurity and resilience R&D for regulated healthcare deployments.
CerviGuard gives cervical-screening teams one traceable path from a new case to a signed-off follow-up decision.
DataGems supports controlled synthetic-data research workflows that stay separate from CerviGuard commercial claims.
CerviGuard is delivered as SmartClover's primary healthcare product. The live product at cerviguard.link and the public repository at SmartCloverAI/CerviGuard provide implementation context for clinical and procurement teams.
CerviGuard is the product we lead with: a live workspace where cervical-screening teams run case intake and AI-assisted review under clinician sign-off.
Deployment conversations can include tenant boundaries, encryption controls, edge/on-prem execution, and traceable release records.
Security/resilience engagements are scoped for healthcare environments and can involve authorized/certified personnel, partner security products, and engineering support where approved.
Flagship product
Live product
Platform capability
Platform capability
Rollouts progress through qualification, legal/security review, environment readiness, and operational handoff. This process aligns commercial scope with governance requirements before production activation.

Scope, evidence, and next steps for a research or product-deployment programme.